Zactima With Temodar During Radiation Treatment for Newly Diagnosed Stage IV Brain Tumors

This study is ongoing, but not recruiting participants.
Sponsor:
Collaborators:
Dana-Farber Cancer Institute
Beth Israel Deaconess Medical Center
Massachusetts General Hospital
University of Virginia
Memorial Sloan-Kettering Cancer Center
Henry Ford Hospital
Information provided by (Responsible Party):
Patrick Y. Wen, MD, Dana-Farber/Brigham and Women's Cancer Center
ClinicalTrials.gov Identifier:
NCT00441142
First received: February 27, 2007
Last updated: June 11, 2014
Last verified: June 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: February 2015
  Primary Completion Date: August 2013 (Final data collection date for primary outcome measure)